Ceftazidime Container, Ceptaz, Fortaz, Zavicefta (ceftazidime) is a small molecule pharmaceutical. Ceftazidime was first approved as Ceftazidime Container on 1985-07-19. It is used to treat acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, and bacterial skin diseases amongst others in the USA. It has been approved in Europe to treat bacterial pneumonia, gram-negative bacterial infections, pneumonia, soft tissue infections, and urinary tract infections.
|Indication||acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, bacterial skin diseases, escherichia coli infections, fever, gram-negative bacterial infections, haemophilus infections, infectious bone diseases, klebsiella infections, neutropenia, pneumonia, proteus infections, pseudomonas infections, sepsis, serratia infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections|